1 Min Read
Oct 18 (Reuters) - Actinium Pharmaceuticals Inc :
* Actinium Pharmaceuticals granted orphan designation from the European Medicines Agency for Iomab-B Source text for Eikon: Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.